Target intelligence / Profile preview

B-cell receptor repertoire (BCR repertoire)

Target
BCR repertoire
Molecular classification
Receptor, Immunoglobulin
01

Overview

The B-cell receptor (BCR) repertoire specific for vaccine antigens is the collection of unique antigen-binding receptors expressed by B cells that have been activated or selected by a vaccine (Nielsen et al., 2018, Nature Reviews Rheumatology). Each BCR consists of two identical heavy chains and two identical light chains, forming a complex that recognizes specific epitopes on the vaccine's immunogen (Janeway et al., 2001, Immunobiology). Upon binding, the BCR initiates intracellular signaling pathways that lead to B-cell proliferation, isotype switching, and somatic hypermutation within germinal centers (Victora & Nussenzweig, 2012, Annual Review of Immunology). This process results in the expansion of high-affinity clones that provide long-term immunity through the production of neutralizing antibodies and the establishment of memory B-cell populations (Galson et al., 2014, Frontiers in Immunology). Analyzing the diversity and evolution of this repertoire is a key component of modern vaccinology, used to evaluate the breadth of protection and to guide the development of next-generation vaccines (Phad et al., 2020, Trends in Immunology). While the repertoire itself is a biological readout rather than a single druggable molecule, it is the fundamental basis for the efficacy of all B-cell-mediated vaccines (Wen et al., 2022, Nature Communications).

Other names
Immunoglobulin repertoireIg repertoireVaccine-induced BCR repertoireAntibody repertoireB-cell receptor library
02

Mechanism of action

Vaccines act as exogenous antigens that bind to and cross-link specific B-cell receptors, initiating clonal expansion, somatic hypermutation, and affinity maturation to generate a protective antibody response (Janeway et al., 2001, Immunobiology).

03

Biological functions

Immune responseAntigen recognitionAntibody productionImmunological memoryAffinity maturation
04

Disease associations

InfectionAutoimmunityCancer
05

Safety considerations

Original antigenic sin (interference from prior immunity) (Phad et al., 2020, Trends in Immunology)Antibody-dependent enhancement (ADE) (Wen et al., 2022, Nature Communications)Autoimmune cross-reactivity (induction of self-reactive clones) (Nielsen et al., 2018, Nature Reviews Rheumatology)Repertoire holes (lack of diversity limiting efficacy) (Nielsen et al., 2020, ThermoFisher)
06

Interacting drugs

Vaccines (e.g., mRNA-1273, BNT162b2)

3 more in the full profile.

07

Biomarkers

Clonal expansion of antigen-specific B-cell lineages (Galson et al., 2014, Frontiers in Immunology)Somatic hypermutation (SHM) frequency and rate (Nielsen et al., 2018, Nature Reviews Rheumatology)Complementarity-determining region 3 (CDR3) length distribution and diversity (Pineda et al., 2019, PNAS)Isotype distribution and class-switch recombination frequency (Wen et al., 2022, Nature Communications)Repertoire convergence across individuals (public clonotypes) (Nielsen et al., 2020, ThermoFisher)

Beyond the preview

Go deeper on B-cell receptor repertoire (BCR repertoire).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell receptor repertoire (BCR repertoire).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call